When target cells fail to respond effectively to normal insulin concentrations, pancreatic insulin secretion increases in compensation, leading to hyperinsulinemia, which can affect cell proliferation and metabolism, and promote tumor formation. This evidence concerns the gene INS and hyperinsulinism.